Al-Dughaishi, M., Shalaby, A., Al-Ribkhi, K., Boudaka, A., Boulassel, M.-R., & Saleh, J. (2019). The Value of Programmed Death Ligand 1 Expression in Cancer Patients Treated with Neoadjuvant Chemotherapy. Sultan Qaboos University Medical Journal, 19(4), e277–283. https://doi.org/10.18295/squmj.2019.19.04.002